NO883987L - Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter. - Google Patents

Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.

Info

Publication number
NO883987L
NO883987L NO88883987A NO883987A NO883987L NO 883987 L NO883987 L NO 883987L NO 88883987 A NO88883987 A NO 88883987A NO 883987 A NO883987 A NO 883987A NO 883987 L NO883987 L NO 883987L
Authority
NO
Norway
Prior art keywords
bicycloylkylide
aclylide
medicines
condensed
substituted
Prior art date
Application number
NO88883987A
Other languages
English (en)
Other versions
NO883987D0 (no
Inventor
Gregory Michael Shutske
Kevin James Kapples
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO883987D0 publication Critical patent/NO883987D0/no
Publication of NO883987L publication Critical patent/NO883987L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/08Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO88883987A 1987-09-08 1988-09-07 Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter. NO883987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9418187A 1987-09-08 1987-09-08
US22384888A 1988-07-25 1988-07-25

Publications (2)

Publication Number Publication Date
NO883987D0 NO883987D0 (no) 1988-09-07
NO883987L true NO883987L (no) 1989-03-09

Family

ID=26788584

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883987A NO883987L (no) 1987-09-08 1988-09-07 Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.

Country Status (11)

Country Link
EP (1) EP0306826A1 (no)
JP (1) JPH01131161A (no)
KR (1) KR890005059A (no)
AU (1) AU609872B2 (no)
DK (1) DK497788A (no)
FI (1) FI884105A (no)
HU (1) HU203536B (no)
IL (1) IL87678A (no)
NO (1) NO883987L (no)
NZ (1) NZ226055A (no)
PT (1) PT88443B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175172A (en) * 1988-12-19 1992-12-29 Francois Dietlin Method of alleviating AIDS symptoms and compositions therefor
US4999358A (en) * 1989-06-26 1991-03-12 Hoechst-Roussel Pharmaceuticals Inc. (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179383B1 (en) * 1984-10-25 1991-05-29 Hoechst-Roussel Pharmaceuticals Incorporated 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
IL87678A0 (en) 1989-02-28
KR890005059A (ko) 1989-05-11
PT88443B (pt) 1992-10-30
FI884105A (fi) 1989-03-09
FI884105A0 (fi) 1988-09-06
HU203536B (en) 1991-08-28
AU609872B2 (en) 1991-05-09
DK497788A (da) 1989-03-09
IL87678A (en) 1993-03-15
PT88443A (pt) 1989-07-31
NZ226055A (en) 1991-08-27
NO883987D0 (no) 1988-09-07
DK497788D0 (da) 1988-09-07
AU2193588A (en) 1989-03-09
EP0306826A1 (en) 1989-03-15
JPH01131161A (ja) 1989-05-24
HUT49333A (en) 1989-09-28

Similar Documents

Publication Publication Date Title
NO871640L (no) Fremgangsmaate for fremstilling av n-(2[-aminofenyl)-benzamidderivater.
NO862899D0 (no) Granulert tilsetningsmiddel for vaskemidler, fremgangsmaate for fremstilling av dette og anvendelse av dette.
NO880473L (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner og deres anvendelse som legemiddel.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO882562D0 (no) Nye 2-guanidino-tiazol-forbindelser fremgangsmaate for fremstilling derav og anvendelse derav.
NO860733L (no) N-(2-klor-4-trifluormethylfenyl)-3-trifluormethyl-benzensulfonamidderivat, fremgangsmaate for fremstilling av dette, og fungicid middel inneholdende dette.
NO900643L (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
NO874268L (no) Fremgangsmaate for fremstilling av n-substituerte piperazinoner.
DK635988A (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
NO883986D0 (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
NO884324D0 (no) Fremgangsmaate til fremstilling av reninhemmende peptider og deres anvendelse.
NO873514D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
NO881713L (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
DK34888D0 (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
NO883987L (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.
NO905543D0 (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO871484L (no) Fremgangsmaate for fremstilling av n-(sulfonylmetyl) formamider.
NO894516D0 (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
NO874136D0 (no) Fremgangsmaate for fremstilling av n-(omega-cyanoalkyl)aminofenoler.
NO901892L (no) Fremgangsmaate for fremstilling av (2,1-c)(1,3)-benzodiazepiner og deres anvendelse som medikamenter.
NO891987D0 (no) Fremgangsmaate for fremstilling av n-substituerte fenyltioaniliner, fenylsulfinylaniliner og fenylsulfonylaniliner.
NO912279D0 (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.
NO166447C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomt n-(1-cyclohexenylmethyl-2-pyrrolidinylmethyl)-8-ethylsulfonyl-1,5-benzodioxepan-6-carboxamid.
NO164539C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 5-nafthyl-2,4-dimethyl-3h-1,2,4-triazol-3-thion.